Breaking News: Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Instructions to Continental Stock Transfer & Trust Company for SCILEX Holding Co. Dividend

Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Specific…

San Diego, Feb. 03, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) held by Sorrento.

Sorrento Therapeutics, Inc. made a significant announcement today, highlighting the distribution of dividend confirmation statements to 146 brokerage firms. This action was taken in response to the recent dividend paid out to stockholders of shares of common stock of Scilex Holding Company held by Sorrento. The company made sure to provide specific details in these statements, including account numbers and the amount of the dividend distributed.

Expanding on the Topic

This move by Sorrento is a strategic decision aimed at maximizing shareholder value and ensuring transparency in the distribution of dividends. By providing detailed confirmation statements to brokerage firms, Sorrento is fostering trust and confidence among investors in its commitment to fair and equitable dividend payments.

Additionally, this action also reflects Sorrento’s strong financial position and growth potential as a biopharmaceutical company. By rewarding stockholders with dividends from its holdings in Scilex Holding Company, Sorrento is demonstrating its ability to generate returns for investors and create long-term value.

How This Will Affect Me

As a shareholder of Sorrento Therapeutics, Inc., the distribution of dividend confirmation statements to brokerage firms indicates that the company is actively managing its investments and returning value to its investors. This can be seen as a positive sign of financial stability and growth potential, potentially leading to increased confidence in the company’s stock.

How This Will Affect the World

The distribution of dividend confirmation statements by Sorrento Therapeutics, Inc. to 146 brokerage firms not only impacts individual investors but also has broader implications for the financial market. By providing transparency and clarity in dividend payments, Sorrento is setting a standard for corporate governance and responsible financial management.

Conclusion

In conclusion, Sorrento’s decision to distribute dividend confirmation statements is a step towards enhancing shareholder trust and ensuring accountability in financial transactions. This action reflects the company’s commitment to transparency and investor welfare, ultimately contributing to a more robust and secure financial ecosystem.

Leave a Reply